Work

Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma

Year: 2006

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-005-5211-z

Authors: Thomas Olencki, Sareena Malhi, Tarek Mekhail, Robert Dreicer, Paul Elson, Laura Wood, Ronald M. Bukowski

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, Wenatchee Valley Hospital & Clinics, Cleveland Clinic

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Celgene

OpenAlex ID: W2004477203

FWCI: 1.172

Cites: 18

Cited by: 9

Related to: 10